PharmAla Biotech Holdings, Inc. (TSE:MDMA) has released an update.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
PharmAla Biotech Holdings Inc., a biotech firm specializing in MDMA-related products, announces the successful closure of a $750,000 private placement. This financing will support the company’s patent acquisitions, product manufacturing, clinical trials, and general corporate needs. In parallel, the company has settled a $108,000 debt with shares to conserve cash for operational expenses.
For further insights into TSE:MDMA stock, check out TipRanks’ Stock Analysis page.
